Our private equity strategy invests in established, profitable businesses with enterprise values between $100 million and $500 million, taking control or significant minority positions. We partner with management teams in target sectors, offering patient capital, operational expertise, and a long-term ownership approach.
Across seven funds and over 120 investments, our strategy has delivered top quartile returns for LPs, driven mainly by earnings growth and operational improvement rather than financial engineering or multiple expansion.
Fund VII closed in March 2026 with $800 million in committed capital and is now actively investing. We typically hold investments for five to ten years, but our patient capital structure allows for longer periods when appropriate.